Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by made2laston Dec 10, 2018 1:22pm

169 Views

Post# 29092538

New CEO’s vs Financing

Hi All;

While we are in “Hurry Up And Wait” mode, I am trying to reconcile the CEO application deadline scheduled for December 15th, the 12 month cystoscopey of patient 6 scheduled for early February, and the financing needed to proceed with the NMIBC phase 2 clinical trial.

If I were serious about applying to be a CEO, I would want to know that the company has the financial ability to move forward with their business plan. What applicant would wait until February to see if the company “maybe” will now get financed?

That leads me to believe that we will have our financial requirements met in the near future.

Thoughts?

The best of luck to all longs.

made2last

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario